Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism

Heart

Volumn 96, Issue 12, 2010, Pages 967-973

  Wahl, Andreas ^a   Praz, Fabien ^a   Tai, Tony ^a   Findling, Oliver ^a   Walpoth, Nazan ^a   Nedeltchev, Krassen ^a   Schwerzmann, Markus ^a   Windecker, Stephan ^a   Mattle, Heinrich P ^a   Meier, Bernhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLIP; COHORT ANALYSIS; CONTROLLED STUDY; EMBOLISM; FEMALE; HEADACHE; HEART FORAMEN OVALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATENT FORAMEN OVALE; PREVALENCE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

EID: 77953723161     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.181156     Document Type: Article

References (33)

1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160.
2. Post MC, Luermans JG, Plokker HW, et al. Patent foramen ovale and migraine. Catheter Cardiovasc Interv 2007;69:9-14.
3. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998;8:327-30. (Pubitemid 128721363)
4. Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: a transcranial doppler study. Neurology 1999;52:1622-5. (Pubitemid 29220637)
5. Schwerzmann M, Nedeltchev K, Lagger F, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005;65:1415-18.
6. Sztajzel R, Genoud D, Roth S, et al. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002;13:102-6.
7. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001;100:215-20.
8. Wilmshurst PT, Pearson MJ, Nightingale S, et al. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004;90:1315-20.
9. Rundek T, Elkind MS, Di Tullio MR, et al. Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 2008;118:1419-24.
10. Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-51.
11. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-401.
12. Post MC, Thijs V, Herroelen L, et al. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439-40.
13. Azarbal B, Tobis J, Suh W, et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005;45:489-92.
14. Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-5.
15. Giardini A, Donti A, Formigari R, et al. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006;151:922 e1-5.
16. Slavin L, Tobis JM, Rangarajan K, et al. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 2007;99:1316-20.
17. Rigatelli G, Cardaioli P, Braggion G, et al. Resolution of migraine by transcatheter patent foramen ovale closure with premere occlusion system in a preliminary series of patients with previous cerebral ischemia. Catheter Cardiovasc Interv 2007;70:429-33.
18. Dubiel M, Bruch L, Schmehl I, et al. Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol 2008;21:32-7.
19. Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003;16:39-42.
20. Anzola GP, Frisoni GB, Morandi E, et al. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006;37:430-4.
21. Vigna C, Marchese N, Inchingolo V, et al. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study. JACC Cardiovasc Interv 2009;2:107-13.
22. Post MC, Thijs V, Schonewille WJ, et al. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006;66:202-5.
23. Dowson A, Mullen MJ, Peatfield R, et al. Migraine intervention with starflex technology (mist) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-404.
24. Pearson AC, Nagelhout D, Castello R, et al. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223-9.
25. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
26. Wahl A, Meier B. Patent foramen ovale and ventricular septal defect closure. Heart 2009;95:70-82.
27. Wahl A, Tai T, Praz F, et al. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer pfo occluder without intraprocedural echocardiography: effect of device size. JACC Cardiovasc Interv 2009;2:116-23.
28. Meier B. Pacman sign during device closure of the patent foramen ovale. Catheter Cardiovasc Interv 2003;60:221-3.
29. Wahl A, Praz F, Seiler C, et al. Clinical relevance of coronary angiography at the time of percutaneous closure of a patent foramen ovale. Catheter Cardiovasc Interv 2007;70:641-5.
30. Wahl A, Praz F, Findling O, et al. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment. Catheter Cardiovasc Interv 2009;74:130-1.
31. Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988;296:313-16.
32. Diener HC, Hartung E, Chrubasik J, et al. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001;21:120-8.
33. Wilmshurst PT, Nightingale S, Walsh KP, et al. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005;91:1173-5.